SAM
BLFS icon

Silvercrest Asset Management’s BioLife Solutions BLFS Stock Holding History

Silvercrest Asset Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-194,743
Closed -$5.64M – 815
2020
Q3 		$5.64M Sell
194,743
-41,266
-17% -$891K 0.05% 316
2020
Q2 		$3.86M Buy
+236,009
New +$3.25M 0.03% 375

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Silvercrest Asset Management's BLFS Position: Q4 2020 in Review

Silvercrest Asset Management sold out of BioLife Solutions (BLFS) in Q4 2020, closing a stake of 194,743 shares — an estimated $5.64M sold.

Silvercrest Asset Management first reported a position in BLFS in Q2 2020 and held it in 2 quarters. The position peaked at $5.64M in Q3 2020. 128 funds tracked by Wall St. Rank hold BLFS as of Q4 2020.

  • Silvercrest Asset Management reported no remaining BioLife Solutions position as of Q4 2020 after selling out during the quarter.
  • Silvercrest Asset Management sold 194,743 BioLife Solutions shares in Q4 2020, an estimated $5.64M.
  • Silvercrest Asset Management first reported a position in BioLife Solutions in Q2 2020 and held it in 2 quarters.
  • Silvercrest Asset Management's BioLife Solutions position peaked at $5.64M in Q3 2020.
  • 128 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2020.

Based on Silvercrest Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.